Six New Billion-Dollar Valuations in 72 Hours: Inside Q1's Final VC Sprint

In the span of 72 hours, six startups either reached or surpassed billion-dollar valuations. Shield AI hit $12.7 billion. Harvey crossed $11 billion. A Swedish rug company — yes, a rug company — touched €1.9 billion. Across 127 venture deals tracked between March 25 and 28, more than $43 billion in capital changed hands.

The quarter isn't over, but Q1 2026 is already making its closing argument. And it's doing so with a velocity that raises a question worth sitting with: is this a rational acceleration, or the early stages of another cycle that ends badly?

The Unicorn Factory Runs a Double Shift

The six companies that crossed the billion-dollar threshold in this 72-hour window span wildly different sectors. Shield AI builds autonomous military aircraft and saw its valuation jump 140% after a U.S. Air Force contract. Harvey is scaling AI agents for law firms. Dash0, an observability platform barely a year old, raised $110 million to reach $1 billion. Granola hit $1.5 billion by expanding from a meeting notetaker into an enterprise AI platform.

Then there's Nordic Knots, the most unexpected entry on the list. The Swedish direct-to-consumer brand reached a €1.9 billion valuation on just €86 million in new funding — a signal that consumer brands with genuine pricing power can still command premium multiples in a market obsessed with enterprise software.

Aetherflux, a satellite-based energy transmission startup, is reportedly raising its Series B at a $2 billion valuation, though that deal has not been confirmed. If it closes, it would make space-based solar power a funded thesis rather than a whiteboard sketch.

Where the Capital Actually Went

Strip away the headline-grabbing unicorn rounds and the underlying deal flow tells a more nuanced story. Of 127 VC deals tracked in this window, 57 were early-stage — Pre-Seed through Series A. Those 57 deals raised a combined $455 million. Meanwhile, the top five deals alone accounted for over $12 billion.

Series A rounds averaged $24 million across 19 deals, with Isembard ($50 million for industrial AI led by Union Square Ventures) and ODC ($45 million for distributed compute infrastructure) at the top end. At the bottom, Chexy raised $14 million from Khosla Ventures for rent payments, and Scalvy closed $13.9 million.

Seed rounds showed similar range. ai& raised a $50 million seed — a number that would have been a respectable Series B three years ago — while CurrentClient closed at $1.25 million. The median seed round landed around $5 million, which is roughly double where it sat in 2023.

Series B was dominated by a few large rounds: Qualified Health ($125 million for healthcare AI), Dash0 ($110 million), and Pinnacle Medicines ($89 million). Spade raised $40 million for a finance data platform, and Tazapay closed $36 million for cross-border payment rails.

The Capital Concentration Problem

The deal-size distribution chart above tells one of the most important stories in venture capital right now. Deals under $5 million — 21 of them — totaled $53 million. Deals above $500 million — just a handful — accounted for $12 billion. That's a 226-to-1 ratio in capital per bracket, with deal counts that are almost inverted.

This isn't new, but the degree is intensifying. When OpenAI secures an additional $10 billion and Shield AI raises $2 billion in a single week alongside dozens of $2–5 million seed rounds, the market is effectively operating as two separate ecosystems with different rules, different investor bases, and different return profiles.

For founders at the early stage, the practical implication is clear: there's plenty of seed and Series A capital available, but the jump to a $100 million+ round requires either an AI narrative or category dominance. The middle — the $30–80 million range — is where competition for dollars is fiercest.

Beyond Venture: M&A and PE Were Busy Too

Venture capital grabbed most of the deal count, but M&A and private equity moved serious capital. CVC tabled a €10.9 billion indicative offer for Recordati, the Italian pharma group — one of the largest European take-private bids of the year. Brookfield and LaCaisse agreed to take Boralex private for C$9 billion, adding another infrastructure asset to Brookfield's growing portfolio.

Gilead Sciences acquired Ouro Medicines for $1.7 billion to advance autoimmune therapies, continuing big pharma's pattern of buying clinical-stage biotech rather than building in-house. Advent exited Olaplex in a $1.4 billion sale to Henkel, marking a successful PE exit in the premium beauty category.

On the fund formation side, Hale secured A$750 million for a logistics-focused fund anchored by Oxford and Warburg Pincus, and MidPoint Capital unveiled a $500 million bridge lending fund. Ysios Capital launched a €100 million biotech creation fund in Spain — a reminder that fund formation in Europe remains active even as deal pace fluctuates.

The AI Tax and the Non-AI Opportunity

Roughly a third of the VC deals tracked in this window had some AI component — whether explicit in the company name or embedded in the product description. The largest rounds skewed heavily toward AI: Harvey, Granola, Qualified Health, Dash0, Deccan AI. That's not surprising. What's more interesting is what's happening outside the AI bubble.

Lovable raised $330 million for developer tools. Cloaked raised $375 million for identity security. Cambridge Mobile Telematics raised $350 million for insurance telematics. Xona raised $170 million for satellite navigation. These are large, late-stage rounds flowing into companies that may use AI internally but aren't selling it as the product.

At the seed stage, the non-AI deals are even more revealing: Helix Earth ($12 million for climate tech), Applied Atomics ($8 million), and Conntour ($7 million). The narrative that "only AI gets funded" is lazy. Capital is available for hard problems in infrastructure, defense, health, and climate — it's just quieter about it.

Reading Q1's Exit Ramp

Two hundred deals in three days, six new billion-dollar companies, and tens of billions deployed across every asset class. The pace is real. The capital is real. The question is whether the pricing is.

A $50 million seed round. A rug company at $1.9 billion. A one-year-old observability startup at $1 billion. These aren't necessarily wrong — Dash0's founders previously built Instana, which IBM acquired, and Nordic Knots reportedly has genuine margins to justify its multiple. But they set a bar that demands execution.

What the data from this 72-hour window suggests is that Q1 2026 will close with venture capital in its most confident posture since early 2022. The money is there. The deals are closing fast. And the spread between the biggest rounds and the smallest is wider than it has ever been. For LPs, the concentration risk is obvious. For founders, the message is equally clear: the capital exists, but it's flowing to conviction, not experimentation. If you're raising, have the numbers. If you're investing, know which side of the barbell you're on.